Avalyn Pharma Inc experienced significant insider activity on May 1, 2026, when multiple entities and individuals executed substantial purchase orders. SR One Capital Management, Novo Holdings, and Jill Carroll collectively acquired over 1.3 million shares. These transactions represent the most recent recorded trading events for the firm, occurring more than three months ago.